Infusion of Mesenchymal Stem Cells Protects Lung Transplants from Cold Ischemia-Reperfusion Injury in Mice
- 26 October 2014
- journal article
- Published by Springer Science and Business Media LLC in Lung
- Vol. 193 (1), 85-95
- https://doi.org/10.1007/s00408-014-9654-x
Abstract
Cold ischemia-reperfusion injury (IRI) is a major cause of graft failure in lung transplantation. Despite therapeutic benefits of mesenchymal stem cells (MSCs) in attenuating acute lung injury, their protection of lung transplants from cold IRI remains elusive. The present study was to test the efficacy of MSCs in the prevention of cold IRI using a novel murine model of orthotopic lung transplantation. Donor lungs from C57BL/6 mice were exposed to 6 h of cold ischemia before transplanted to syngeneic recipients. MSCs were isolated from the bone marrows of C57BL/6 mice for recipient treatment. Gas exchange was determined by the measurement of blood oxygenation, and lung injury and inflammation were assessed by histological analyses. Intravenously delivered MSC migration/trafficking to the lung grafts occurred within 4-hours post-transplantation. As compared to untreated controls, the graft arterial blood oxygenation (PaO2/FiO2) capacity was significantly improved in MSC-treated recipients as early as 4 h post-reperfusion and such improvement continued over time. By 72 h, oxygenation reached normal level that was not seen in controls. MSCs treatment conferred significant protection of the grafts from cold IRI and cell apoptosis, which is correlated with less cellular infiltration, a decrease in proinflammatory cytokines (TNF-α, IL-6) and toll-like receptor 4, and an increase in anti-inflammatory TSG-6 generation. MSCs provide significant protection against cold IRI in lung transplants, and thus may be a promising strategy to improve outcomes after lung transplantation.This publication has 33 references indexed in Scilit:
- Role of innate immunity in primary graft dysfunction after lung transplantationCurrent Opinion in Organ Transplantation, 2013
- Ischemia–reperfusion injuryCurrent Opinion in Organ Transplantation, 2013
- Melatonin treatment improves adipose‐derived mesenchymal stem cell therapy for acute lung ischemia–reperfusion injuryJournal of Pineal Research, 2012
- Autologous Transplantation of Adipose-Derived Mesenchymal Stem Cells Markedly Reduced Acute Ischemia-Reperfusion Lung Injury in a Rodent ModelJournal of Translational Medicine, 2011
- TLR4 Mediates Lung Injury and Inflammation in Intestinal Ischemia-ReperfusionJournal of Surgical Research, 2011
- Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological processAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biologyNature Protocols, 2008
- A Mouse Model of Orthotopic Vascularized Aerated Lung TransplantationAmerican Journal of Transplantation, 2007
- Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine MechanismsCirculation Research, 2004